#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11710	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2156	535.1	0	.	n	.	0	C451T	SNP	451	451	C	716	716	T	683	T,C	480,186	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11710	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2156	535.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1449	1449	C	658	C	642	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11710	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2156	535.1	0	HET	.	.	.	C1450T	.	1450	1450	C	1715	1715	C	612	C,T	470,128	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22224	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3569	616.1	0	.	n	.	0	T695C	SNP	695	695	T	990	990	C	726	C,T,G,A	701,1,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22224	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3569	616.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2266	2266	C	686	C,G	670,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22224	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3569	616.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2340	2340	A	687	A	665	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22224	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3569	616.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2892	2892	C	660	C	651	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	22224	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3569	616.1	0	HET	.	.	.	A1638G	.	1638	1638	A	1933	1933	A	700	A,G	534,147	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	106	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1202	8.7	0	.	p	.	0	M180T	NONSYN	538	540	ATG	758	760	ACG	13;13;13	A;C,T;G	12;12,1;13	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	539	1452	folP	855	855	99.88	folP.l15.c4.ctg.1	1448	98.8	0	.	p	.	0	T66M	NONSYN	196	198	ACG	485	487	ATG	134;133;133	A;T,C;G	128;122,4;127	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	539	1452	folP	855	855	99.88	folP.l15.c4.ctg.1	1448	98.8	1	SNP	p	R229S	1	.	.	685	687	AGC	974	976	AGC	157;156;158	A;G;C,A	154;156;154,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4062	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3311	121.6	1	SNP	p	S91F	1	.	.	271	273	TTC	537	539	TTC	154;152;156	T;T,C;C	150;149,3;153	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4062	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3311	121.6	1	SNP	p	D95G	1	.	.	283	285	GGC	549	551	GGC	159;157;158	G;G,A;C	155;150,3;155	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4062	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3311	121.6	1	SNP	p	G95N	0	.	.	283	285	GGC	549	551	GGC	159;157;158	G;G,A;C	155;150,3;155	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1398	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1271	108.6	1	SNP	p	G45D	0	.	.	133	135	GGC	398	400	GGC	169;168;169	G;G,A;C,A	165;159,2;165,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	726	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1116	64.5	0	.	n	.	0	A197.	DEL	197	197	A	667	667	A	166	A	163	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4158	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2935	139.7	1	SNP	p	D86N	0	.	.	256	258	GAC	543	545	GAC	166;166;167	G;A;C,G	164;157;164,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4158	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2935	139.7	1	SNP	p	S87R	1	.	.	259	261	CGT	546	548	CGT	171;171;172	C,A;G;T	166,4;169;163	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4158	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2935	139.7	1	SNP	p	R87I	0	.	.	259	261	CGT	546	548	CGT	171;171;172	C,A;G;T	166,4;169;163	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4158	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2935	139.7	1	SNP	p	R87W	0	.	.	259	261	CGT	546	548	CGT	171;171;172	C,A;G;T	166,4;169;163	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4158	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2935	139.7	1	SNP	p	S88P	0	.	.	262	264	TCC	549	551	TCC	173;175;174	T;C;C	170;171;171	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3076	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2715	112.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1504	1506	GGC	165;164;164	G;G,T;C	161;159,1;156	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	3114	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2320	131.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1256	1258	GCC	170;170;170	G;C;C	164;169;167	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3114	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2320	131.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1259	1261	ATG	171;169;171	A;T;G,C	170;168;169,1	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3114	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2320	131.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1271	1273	ACC	166;164;169	A;C;C,T	156;162;164,1	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3114	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2320	131.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1271	1273	ACC	166;164;169	A;C;C,T	156;162;164,1	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3114	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2320	131.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1772	1774	ACC	136;134;132	A;C;C	129;130;131	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3114	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2320	131.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1826	1828	GCG	131;131;133	G;C,G;G,T	125;111,1;120,1	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3114	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2320	131.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1826	1828	GCG	131;131;133	G;C,G;G,T	125;111,1;120,1	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3114	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2320	131.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1949	1951	GGT	120;119;119	G;G;T,C	116;115;110,2	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3114	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2320	131.9	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1958	1960	GGC	112;111;112	G,A;G;C	105,1;105;105	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	3114	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2320	131.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1976	1978	CCG	100;103;99	C,A;C,T;G	89,1;93,1;79	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4462	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3079	143.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1612	1614	CCG	169;170;164	C,T;C,T;G,C	158,1;164,2;156,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1932	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1774	107.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	582	582	C	134	C	128	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	A251V	NONSYN	751	753	GCG	44	46	GTA	27;27;27	G;T;A	26;26;26	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	S271T	NONSYN	811	813	TCG	104	106	ACT	32;30;29	A,T;C;T	28,1;29;28	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	110	112	GAT	19;18;17	G,C;A;T	18,1;18;17	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	D276N	NONSYN	826	828	GAT	119	121	AAC	18;18;18	A,G;A;C	17,1;17;17	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	N277H	NONSYN	829	831	AAC	122	124	CAC	18;18;18	C,T;A;C	17,1;18;18	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	R307E	NONSYN	919	921	AGA	212	214	GAA	7;7;8	G;A;A	7;7;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	T311A	NONSYN	931	933	ACA	224	226	GCA	9;9;9	G;C;A	9;8;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	E312D	NONSYN	934	936	GAA	227	229	GAC	9;9;9	G;A;C	9;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	F314I	NONSYN	940	942	TTC	233	235	ATC	8;9;9	A;T;C	8;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	A316S	NONSYN	946	948	GCG	239	241	TCG	9;9;9	T;C;G	8;8;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	V318A	NONSYN	952	954	GTC	245	247	GCC	9;9;9	G;C;C	9;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	G319S	NONSYN	955	957	GGC	248	250	AGC	9;10;10	A;G;C	9;9;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	G320A	NONSYN	958	960	GGT	251	253	GCC	10;10;10	G;C;C	8;10;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	188	porB1a	984	271	91.51	porB1a.l15.c17.ctg.2	278	19.2	0	.	p	.	0	G322V	NONSYN	964	966	GGT	257	259	GTT	9;9;9	G;T;T	9;9;9	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2254	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1607	138.3	0	.	p	.	0	I45V	NONSYN	133	135	ATT	465	467	GTT	161;159;162	G;T;T	159;151;160	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2254	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1607	138.3	1	SNP	p	G120K	1	.	.	358	360	AAG	690	692	AAG	173;174;175	A,G;A,G;G,T	162,4;167,4;157,3	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2254	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1607	138.3	1	SNP	p	A121N	1	.	.	361	363	AAC	693	695	AAC	176;175;172	A,G;A,C;C	168,4;168,3;165	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2254	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1607	138.3	1	SNP	p	N121D	0	.	.	361	363	AAC	693	695	AAC	176;175;172	A,G;A,C;C	168,4;168,3;165	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	226	porB3	990	303	90.71	porB3.l6.c30.ctg.2	550	24.4	0	.	p	.	0	S217G	NONSYN	649	651	AGC	55	57	GGC	19;19;19	G;G;C	17;17;17	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	226	porB3	990	303	90.71	porB3.l6.c30.ctg.2	550	24.4	0	.	p	.	0	D222N	NONSYN	664	666	GAT	70	72	AAT	21;21;21	A;A;T	20;20;20	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	226	porB3	990	303	90.71	porB3.l6.c30.ctg.2	550	24.4	0	.	p	.	0	V230A	NONSYN	688	690	GTA	94	96	GCA	18;18;18	G;C;A	18;17;18	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	226	porB3	990	303	90.71	porB3.l6.c30.ctg.2	550	24.4	0	.	p	.	0	V238Y	NONSYN	712	714	GTT	118	120	TAT	10;10;10	T;A;T	9;10;9	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	226	porB3	990	303	90.71	porB3.l6.c30.ctg.2	550	24.4	0	.	p	.	0	.	INDELS	715	717	GAA	122	128	GAGCAAT	10;10;10;9;9;9;9	G;A;G;C;A;A;T	9;9;10;9;9;9;8	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	226	porB3	990	303	90.71	porB3.l6.c30.ctg.2	550	24.4	0	.	p	.	0	.	INDELS	719	720	AC	131	133	GCG	17;21;23	G;C;G	16;19;22	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	226	porB3	990	303	90.71	porB3.l6.c30.ctg.2	550	24.4	0	.	p	.	0	L253V	NONSYN	757	759	TTG	172	174	GTA	33;33;33	G;T,C;A,G	33;31,2;31,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	226	porB3	990	303	90.71	porB3.l6.c30.ctg.2	550	24.4	0	.	p	.	0	S273T	NONSYN	817	819	TCG	232	234	ACT	40;38;37	A,T;C,A;T	34,2;36,1;36	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	226	porB3	990	303	90.71	porB3.l6.c30.ctg.2	550	24.4	0	.	p	.	0	K278N	NONSYN	832	834	AAA	247	249	AAC	27;29;30	A,G;A;C	25,2;28;28	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	226	porB3	990	303	90.71	porB3.l6.c30.ctg.2	550	24.4	0	.	p	.	0	R279H	NONSYN	835	837	CGC	250	252	CAC	33;39;40	C,T;A;C	30,2;37;38	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7986	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4851	162.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	856	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1119	75.8	1	SNP	p	V57M	1	.	.	169	171	ATG	619	621	ATG	164;164;162	A;T;G	162;162;160	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
